Financial report interval: 2025.12.31 - 2026.03.31
Overview: SINOPHARM(CNCM LTD)(600511) the Revenue is 13.56 B (+6.63%);the EBIT is 478.71 M (-0.99%);the EPS is 0.629 (+3.32%).